Pharmaceutical Supply of Potassium Chloride Concentrate

The contract involves the supply of Potassium Chloride Injection, Concentrate, with a concentration of 10 MEQ per 50 mL, packaged in 24-bag units. These supplies must meet stringent compliance standards, including those set by the United States Pharmacopeia (USP), the Food and Drug Administration's current Good Manufacturing Practices (FDA cGMP), and military packaging requirements. The contract is classified as a subcontract under NAICS code 325412, which pertains to pharmaceutical manufacturing. Issued by the Defense Logistics Agency on behalf of the Department of Defense, the solicitation was posted on June 2, 2026, with a response deadline of June 5, 2026, indicating a brief response window. Specific location details for performance and points of contact are not provided. The contracting opportunity is publicly accessible through the Defense Logistics Agency’s online portal, allowing qualified suppliers to submit their offers for this pharmaceutical supply requirement.